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INTRODUCTION
Endovascular aortic repair (EVAR) for thoracic and abdominal
aortic aneurysm has been accepted as a minimally invasive surgery
for aortic aneurysm and dissection in recent history and has been
performed in more patients. The contrast medium used is an in-
evitable cause of acute kidney injury (1, 2), with the resulting
condition referred to as “contrast medium-induced nephropathy
(CIN)”. CIN is a major cause of acute kidney injury in the hospital
(3) and a common associated complication of EVAR (4, 5). It is
associated with a longer hospital stay, renal impairment, and higher
mortality (5, 6). Zarkowsky et al (7). reported that postoperative
renal dysfunction after EVAR was associated with decreased esti-
mated long-term survival. Additionally, CIN is reported to be a risk
factor of cardiac event after percutaneous coronary intervention
(PCI) (8).
Preprocedural renal impairment has been reported to be a risk
factor for developing CIN (9). Additionally, the contrast medium
volume (CV) used in the procedure is also reported to be a risk
factor of CIN (8, 10). The CV/estimated glomerular filtration rate
(CV/eGFR) ratio is reported to be a useful predictor of CIN after
PCI (11, 12).
Prevention of CIN is crucial, and thus, the main objective of this
study was to determine the perioperative predictors of CIN after
EVAR, particularly the CV/eGFR ratio, as well as to evaluate the
relationship between CIN after EVAR, determine clinical out-
comes, and recommend useful approaches for CIN prevention
after EVAR.
MATERIALS AND METHODS
Patient selection
We performed EVAR on 217 consecutive patients at Chiba-Nishi
General Hospital from January 2014 to September 2014. Among
the 217 patients, 14 patients who underwent emergent EVAR for
ruptured aortic aneurysm or EVAR using median thoracotomy pro-
cedure were excluded from this study. We included patients with
aneurysm with and without dissection. The renal arteries of all
patients were patent on preoperative and postoperative CT and in-
traoperative aortography. Based on the definition given by the
European Society of Urogenital Radiology (13), obvious renal
artery occlusion or stenosis during the operation due to device
manipulation or thrombus migration was set as an exclusion crite-
rion. However, no patient was excluded for this reason. Finally, 203
patients who underwent elective EVAR were enrolled in this study
(mean age, 71.410.3 years ; 80.7% men). One hundred patients
underwent EVAR for abdominal aortic aneurysm and 103 patients
underwent EVAR for thoracic aortic aneurysm.
Definition of contrast-induced nephropathy
Iopamidol, a non- ionic high-osmolarity contrast agent, was
used as an intraoperative contrast medium. CIN was defined ac-
cording to the diagnostic criteria of the European Society of Uro-
genital Radiology as “a condition in which a decrease in renal
function within 3 days of the intravascular administration of a CM in
the absence of an alternative etiology. An increase in serum cre-
atinine by more than 25% or 44 μmol/L (0.5 mg/dL) indicates CIN
(13).”
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Data collection and evaluation
All clinical data were retrospectively collected from the patients’
medical records. Data related to the patients’ demographics and
preoperative status were also collected, including age, sex, and
medical history, such as hypertension (patients receiving medica-
tion or remaining untreated), diabetes (patients receiving insulin),
and impaired left ventricular function (ejection fraction30%). The
serum creatinine value obtained from the last blood test before the
day EVAR was performed was used as the preoperative serum cre-
atinine level, and postoperative serum creatinine level was defined
as the highest serum creatinine value obtained during the first to
third postoperative days. We predicted the eGFR using the calcula-
tion method recommended by the Japanese Society of Nephrology
(14) : 194 × serum creatinine level - 1.094 × age - 0.287 (for men) and
194 × serum creatinine level - 1.094 × age - 0.287× 0.739 (for women).
The surgery-related factors were type of procedure (EVAR for
thoracic or abdominal aortic aneurysm), operation time, and quan-
tity of contrast medium used.
The treatment outcomes were hospital death, 1-year survival,
renal replacement therapy, length of ICU stay, and length of
postoperative hospitalization.
Perioperative and intraoperative management
Patients with a preoperative serum creatinine level1.3 mg/dL
were hospitalized before EVAR and received Ringer’s lactate solu-
tion (60 mL/h) intravenously for more than 12 hours. Postopera-
tive initiation of food intake was accompanied by termination of
reinfusion fluid ; in cases where serum creatinine levels remained
elevated, hydration was continued until an improvement in serum
creatinine levels was observed. No patient underwent preoperative
enhanced CT 3 days before the operation.
An anesthesiologist performed intraoperative fluid management,
including fluid control and hemodynamic monitoring, using an
arterial line.
Endovascular aortic repair
All surgeries were performed under general anesthesia. The
access route for stent graft insertion was via the femoral artery
through an inguinal incision ; a sheath was placed in the artery and
the stent graft was inserted. If the landing zone was short, emboliza-
tion of the left subclavian artery or internal iliac artery was per-
formed during EVAR for the thoracic or abdominal aorta, respec-
tively, to lengthen the landing zone sufficiently. Embolization was
accomplished with coils and/or vascular plugs. All patients awoke
in the operating room and were subsequently transferred to the
ICU.
We used endografts such as Conformable GORE TAG (W.L.
Gore & Associates ; Flagstaff, AZ, USA), Relay Plus (Bolton Medi-
cal, Barcelona, Spain), TX2 TAA Endovascular Graft (Cook,
Bloomington, IN, USA) and Valiant Captivia Thoracic Stent Graft
(Medtronic, Santa Rosa, CA, USA) for thoracic aneurysms, and the
Aorfix stent graft (Lombard Medical, Didcot, UK), Endurant II
(Medtronic), GORE EXCLUDER AAA Endoprosthesis (W.L. Gore
& Associates), Powerlink stentgraft (Endologix, Irvine, CA, USA),
and Zenith flex (Cook) for abdominal aneurysms. The endograft
was chosen based on the anatomical features of each patient and
graft availability.
Statistical analysis
Continuous variables are presented as the meanstandard
deviation, and categorical variables are presented as the number
and percentage of the total. Continuous variables were analyzed
using Student’s t - tests, whereas categorical variables were com-
pared using chi -squared tests. Differences were considered statisti-
cally significant if P0.05.
We performed a multiple logistic regression analysis on appro-
priate items with P0.05 in the univariate analyses to examine the
factors with the greatest influence on CIN development. An evalu-
ation of an additional cutoff point of different variables was per-
formed using receiver operator characteristic curve analysis. All
statistical analyses were performed on a personal computer using
the statistical software package SPSS for Mac, version 23 (IBM
Corp., Armonk, NY, USA).
Consent for publication
All patients undergoing surgery at our facility were informed of
the significance of publishing their clinical data at academic meet-
ings or in scientific literature, and they all provided informed con-
sent to participate in studies conducted at our facility. Before using
the patients’ treatment data, we obtained consent from the pa-
tients themselves or from proxies with permission to make deci-
sions on behalf of the patients.
RESULTS
Patient characteristics and CIN
Fourteen patients (6.9%) developed CIN. Table 1 shows patient
characteristics in the CIN and non-CIS groups. Only low left ven-
tricular function was a significant risk factor of CIN ; other patient
characteristics were not significantly different (Table 1).
CIN and risk factors
The volume of contrast medium used during surgery was
greater in the CIN group than the non-CIN group. There were no
significant differences among surgery types (EVAR for the tho-
racic or abdominal aorta), aortic etiology (true aneurysm or aortic
dissection), operation time, and radiation time between the CIN
and non-CIN groups. Preoperative serum creatinine level and
eGFR were significantly higher and lower, respectively, in the CIN
group, compared with those of the non-CIN group. Simultaneous
embolization of the left subclavian artery or internal iliac artery was
performed during EVAR for the thoracic or abdominal aorta, re-
spectively, was performed in 65 cases, which was associated with
CIN. The CV/eGFR ratio was significantly higher in the CIN group
(Table 1).
We performed logistic regression analysis for preoperative
serum creatinine level, low left ventricular function, simultaneous
embolization, and contrast medium volume. We excluded preop-
erative the eGFR and the CV/eGFR ratio in this analysis because
these are scores which were derived from and were strongly
associated with other variables. The results of the analysis revealed
that the preoperative serum creatinine level had the greatest
impact on the development of CIN (Table 2).
In this study, we also evaluated simultaneous arterial emboliza-
tion and CIN. The patients’ characteristics and preoperative renal
function were not significantly different between patients undergo-
ing EVAR with simultaneous arterial embolization (E group) and
those undergoing EVAR without simultaneous arterial emboliza-
tion (N group). However, the volume of the contrast medium was
significantly greater, and fluoroscopy time and operation time were
significantly longer in the E group ; moreover, simultaneous arte-
rial embolization was associated with CIN (Table 3).
ROC analysis for predictors of CIN
ROC analysis was performed on the amount of contrast medium
volume used, preoperative serum creatinine, preoperative eGFR,
and CV/eGFR ratio, which were significant predictors of CIN.
The area under the curve (AUC) of CV/eGFR ratio was 0.782,
which was the greatest among the aforementioned predictors.
CV/eGFR ratio1.62 was considered the most appropriate cutoff
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value (Figure 1), with 85.7% sensitivity and 65.6% specificity for
detecting CIN. More patients with CV/eGFR ratio1.62 were
observed in the CIN group (group odds ratio, 7.694 ; 95% confi-
dence interval, 2.071-28.587, P = 0.001) (Table 1). Serum creatinine
was also adequately high AUC. The cut off value was 1.135. The
sensitivity was 71.4% and the specificity was 88.4%.
Relationship between CIN after EVAR and clinical outcomes
Hospital deaths and 1-year mortality were worse in the CIN
group than in the non-CIN group. The lengths of ICU hospital stay
were longer in the CIN group than in the non-CIN group. Only one
patient received renal replacement therapy in the CIN group, but
the difference was not statistically significant (Table 4).
Relationship between CV/eGFR ratio and the development of CIN
and clinical outcomes
We evaluated the relationship between the development of CIN
and CV/eGFR ratio using the cutoff value obtained in the ROC
analysis (CV/eGFR ratio1.62).
Seventy-two patients had a CV/eGFR ratio1.62, which was
seen in 35% of the enrolled patients. CIN was observed more fre-
quently in patients in the group with CV/eGFR ratio1.62. Addi-
tionally, hospital death and 1-year mortality rate were significantly
higher in patients with CV/eGFR ratio1.62. The length of hospital
stay was significantly longer in patients with CV/eGFR ratio1.62
(Table4).
DISCUSSION
CIN has been studied extensively in PCI and reported to have an
adverse effect on treatment outcomes after PCI. Developing CIN
results in worse treatment outcomes related to mortality, serious
morbidity, and myocardial infarction after PCI (15). Postoperative
renal dysfunction after EVAR has been reported to be associated
with decreased estimated long-term survival (7). Additionally, this
study demonstrated that CIN immediately after EVAR was associ-
ated with more hospital deaths and worsened 1-year mortality.
Therefore, efforts should be undergone to prevent CIN after
EVAR.
Developing CIN after endovascular treatment is associated with
several etiologies and causes including renal vasoconstriction (16),
ischemic and hypoxic damage to the renal medulla (17, 18), and
direct toxic effects to the tubular epithelium (19). Maintaining pre-
operative and postoperative blood perfusion in the kidney and
urine flow is very important to protect kidney function.
Selistre et al (20). reported that heart failure was a risk factor for
CIN after intravenous injection of contrast medium following en-
hanced computed tomography, which is not an invasive procedure
involving hemodynamic change. A few reports on CIN after EVAR
indicated that low left ventricular function (5) and heart failure
were also risk factors for CIN (10). Furthermore, the present study
Table 1. Preoperative patient characteristics, comorbidities, pathophysiological and technical features related to perioperative renal
function and CIN or non-CIN
CIN (n=14) Non-CIN (n=189) Total (n=203) P-value (n=189)
Age, years 76.410.9 71.110.2 71.510.3 0.056
Sex, male/female 14/0 150/39 164/39 0.076
BSA, m2 1.600.169 1.640.188 1.640.180 0.443
BMI, kg/m2 21.64.16 22.83.79 22.73.82 0.316
Hypertension, n (%) 11 (78.6) 142 (75.1) 153 (75.3) 1
Diabetes mellitus, n (%) 0 (0) 5 (2.6) 5 (2.5) 1
Low left ventricular function, n (%) 2 (14.3) 3 (1.6) 5 (2.5) 0.039*
Stroke, n (%) 0 (0) 10 (5.3) 10 (4.9) 0.481
Dyslipidemia, n (%) 5 (35.7) 95 (50.3) 100 (49.3) 0.22
Thoracic/abdominal, n 9/5 91/98 100/103 0.279
Aortic dissection, n (%) 6 (42.9) 52 (27.5) 58 0.230
Simultaneous arterial embolization, n (%) 8 (57.1) 57 (30.2) 65 0.04*
Operation time, min 12658.4 11755.8 11756.4 0.583
Fluoroscopy time, min 24.613.6 21.815.3 22.015.2 0.471
Contrast volume, mL 104.443.0 85.527.8 86.829.4 0.019*
Preoperative creatinine, mg/dL 1.370.58 0.9420.32 0.9710.34 0.001*
Preoperative eGFR, mL/min/1.73 m2 46.719.8 62.918.7 61.819.2 0.013*
CV/eGFR ratio 2.390.98 1.510.74 1.560.79 0.001*
CV/eGFR ratio1.62, n (%) 11 (78.6) 61 (32.3) 72 0.001*
Values are presented as meanstandard deviation or n (%).
Abbreviations : BSA, body surface area ; BMI, body mass index ; TEVAR, thoracic endovascular aortic repair ; eGFR, estimated glomerular filtration
rates ; CV, amount of contrast medium ; CIN, contrast medium-induced nephropathy.
Low left ventricular function was defined as left ventricular ejection fraction of 30% or below.
*Statistically significant.
Table2. Factors associated with the development of CIN.
Odds ratio P-value 95% CI
Contrast medium volume 1.07 0.020 1.01 -1.13
Low left ventricular function 19.53 0.008 2.19 -173.80
Preoperative serum creatinine level 64.75 0.006 3.30 -1270.86
Simultaneous arterial embolization 2.54 0.202 0.607-10.63
Abbreviations : CIN, contrast -induced nephropathy ; CI, confidence
interval.
Low left ventricular function was defined as left ventricular ejection
fraction of 30% or lower.
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also demonstrated that low left ventricular function was a risk factor
for CIN. These results suggest that lower renal perfusion due to low
left ventricular function is suspected in CIN pathophysiology.
As Li H et al (21). demonstrated that lower systolic arterial pres-
sure was associated with developing CIN, unstable hemodynamics
during surgery may contribute to the development of CIN. It is very
important to preserve renal perfusion and urinary flow before and
during EVAR to protect the kidney. It is believed that increasing
renal blood flow and urinary flow through hydration can reduce the
renal exposure to contrast media (13, 22). We assumed that pa-
tients with a preoperative serum creatinine level1.3 mg/dL
were at great risk for CIN. According to the Canadian Association of
Radiologists consensus guidelines for prevention, we adminis-
tered Ringer’s lactate solution (60 mL/h) intravenously for more
than 12 hours to these patients (23). Although it was expected that
the fluid infusion contributed to the prevention of CIN, 14 patients
developed CIN.
Diabetes mellitus is a well -known risk factor for CIN, but it was
not a significant risk factor in this study. One of the reason might be
the definition ofdiabetes in this study. We set diabetes mellitus
as insulin dependent diabetes, which made the prevalence of
diabetes very low. If we had used another definition such as “patients
who took oral hypoglycemic agents or patients receiving insulin”,
the prevalence might have been higher and the results of statistical
analysis might have been different.
Although further analysis of long-term results is required, we
anticipate that maintaining stable hemodynamics by fluid infusion
and administrating inotropes particularly in patients with low left
ventricular function will lead to better outcomes with less inci-
dence of CIN.
In this study, the amount of contrast medium used during sur-
gery was larger in the CIN group than in the non-CIN group. Addi-
tionally, we revealed that performing simultaneous embolization of
the left subclavian or internal iliac artery during EVAR for tho-
racic or abdominal aortic aneurysm, respectively, was associated
with the development of CIN. The amount of contrast medium used
during surgery, operation time, and fluoroscopy time were greater in
patients who underwent arterial embolization during EVAR than in
those who underwent EVAR only. We strongly suspect that the
increased amount of contrast medium administered in the em-
bolization procedure was a cause of CIN development because, al-
though the patients’ characteristics and preoperative renal func-
tion did not differ significantly between the two groups, the contrast
medium volume and CV/eGFR ratio were greater in patients un-
dergoing simultaneous arterial embolization. Tran et al (24). re-
ported that in patients who underwent fenestrated EVAR for jux-
tarenal or paravisceral aortic aneurysm, fluoroscopy time, opera-
tive time, and contrast volume were associated with the develop-
ment of CIN. In addition, they concluded that increased surgical
complexity was a risk factor for CIN. They suggested that mini-
mizing surrogate markers for operative complexity is important
(24). We also suggest that additional endovascular procedures
should be performed in patients who have preoperative risk factors
for CIN, including embolization of arteries separately from EVAR
to minimize the complexity of the operation. This involves reduc-
ing the amount of contrast medium used in each procedure to pre-
vent CIN.
In many fields including EVAR, preoperative renal impairment
Table 3. Relationship between pathophysiological and technical features related to perioperative renal function and simultaneous arterial
embolization
Egroup(n=65) Ngroup(n=138) Total (n=203) P-value
Age, years 73.69.9 71.310.4 71.510.3 0.426
Sex, male/female 56/9 108/30 164/39 0.183
BSA, m2 1.60.19 1.60.12 1.640.18 0.280
BMI, kg/m2 22.63.5 22.84.0 22.73.8 0.398
Operation time, min 141.951.0 106.354.2 117.056.4 0.001*
Fluoroscopy time, min 32.718.6 16.99.7 22.015.2 0.001*
Contrast volume, mL 105.425.6 78.016.7 86.829.4 0.001*
Preoperative creatinine, mg/dL 0.980.34 0.970.36 0.9710.36 0.428
Preoperative eGFR, mL/min/1.73 m2 61.819.7 61.818.8 61.819.2 0.500
CV/eGFR ratio 1.930.89 1.360.65 1.560.79 0.001*
CIN, n (%) 8 (12.3) 6 (4.3) 14 (6.9) 0.040*
Values are presented as meanstandard deviation, n (%), or n/n.
Egroup, patients undergoing EVAR with arterial embolization ; N group, patients undergoing EVAR without arterial embolization.
Abbreviations : BSA, body surface area ; BMI, body mass index ; eGFR, estimated glomerular filtration rates ; CV/eGFR ratio, contrast medium
volume/estimated glomerular filtration rate ; CIN, contrast medium-inducednephropathy ; EVAR, endovascular aortic repair.
*Statistically significant.
Fig 1. ROC analysis about the amount of used contrast medium, preop-
erative serum creatinine, preoperative eGFR and CV/eGFR ratio. The
area under the curve of the CV/eGFR ratio was the greatest of the above
four factors.
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was reported to be a risk factor for CIN (25). Serum creatinine
level is a widely used indicator of renal function. Moreover, a high
preoperative creatinine level has been reported to be a risk factor
for CIN (26). However, serum creatinine level does not increase
until the eGFR has decreased by 50% or more (27). We used
eGFR to consider the predictive value of the CV/eGFR ratio.
The CV/eGFR ratio represents a comparison between the pa-
tient’s preoperative risk factors and the potential harm of the
contrast medium volume used in EVAR. On ROC analysis, CV/
eGFR ratio was the most appropriate predictive value, and the opti-
mal cutoff value was 1.62.
The CV/eGFR ratio could predict CIN appropriately. In addition,
interestingly, patients with an CV/eGFR ratio1.62 required a
longer hospital stay and had increased likelihood of hospital death
and worsened 1-year mortality. The present results suggest that a
CV/eGFR ratio1.62 was a useful predictor for developing CIN
and worsened outcomes after EVAR. Our study results imply that
consideration of both the contrast medium volume and the preop-
erative renal impairment are more useful predictors of CIN in EVAR
than those of CIN in PCI.
We performed EVAR under general anesthesia. Generally, the
general anesthesia has more negative chronotropic and inotropic
effects than the local anesthesia commonly used for PCI. There-
fore, hemodynamic status during EVAR affects not only the preserva-
tion of renal function, but it also the development of CIN more than
those during PCI. It is not appropriate to use the cutoff value
based on another endovascular method such as PCI. Some studies
on the usefulness of the CV/eGFR ratio in PCI have calculated
these cutoff values. One study (14) focused on CIN after PCI pro-
posed a cutoff value of CV/eGFR ratio3.1, which was greater than
the cutoff value of 1.62 obtained in this study. This difference in
optimal cutoff values among endovascular procedures must be
clarified. This study is valuable because there are very few reports
on the cutoff value for preventing CIN after EVAR.
Using the CV/eGFR ratio of 1.62 in each patient, we can calculate
the amount of contrast medium necessary and determine the
risk of developing CIN before surgery. Thus, we can decide on the
amount of contrast medium needed for each surgery and balance
the amount with the technical requirement and risk of CIN in each
patient objectively, and not based on the surgeon’s experience.
Using the CV/eGFR ratio cutoff value (1.62) appropriately can im-
prove the safety of EVAR in terms of preventing CIN.
In addition to CV/eGFR, serum creatinine also had adequately
high AUC. We assume that serum creatinine is also important pre-
dictor for CIN after EVAR. Serum creatinine is a preoperative value,
which does not include intraoperative factor such as CV. There-
fore, using serum creatinine, we can predict CIN before opera-
tions based on patients’ background. The results about serum cre-
atinine can be useful for prevention of CIN. We performed intrave-
nous hydration in the patients with serum creatinine level above
1.3. But according to the result in this study (appropriate cut off
value of serum creatinine was 1.135), we have to set more strict
criteria for intravenous hydration. It may be appropriate to perform
intravenous hydration in patients with serum creatinine level above
1.135. Serum creatinine and CV/eGFR are both useful for predict-
ing CIN after EVAR. But, CV/eGFR is useful not only for predicting
CIN but also planning operation procedure including the amount of
contrast medium volume use.
This study has some limitations. First, it included a small
number of cases and followed a retrospective design. Second, the
study participants had small differences in characteristics such as
lower BMI and BSA than those in Western patients. In addition, we
used only one contrast medium (iopamidol). The subjects of this
study were elderly patients. Therefore, it was possible that we un-
derestimated eGFR. Using cystatin C could have enabled us to
estimate GFR more precisely, and could have made CV/eGFR
more accurate. Further prospective studies with a large number of
patients including many races and more than one contrast agent
are needed to confirm the efficacy of the CV/eGFR ratio for pre-
venting CIN.
CONCLUSION
This study demonstrated that the CV/eGFR ratio was an appro-
priate predictor of CIN development after EVAR. We can calcu-
late the safe maximum amount of contrast medium in each patient
using the CV/eGFR ratio cutoff value of 1.62. We recommend
taking the preoperative predictive value of an individual patient into
account and managing the EVAR techniques and CV. Conse-
quently, we will be able to reduce the incidence of CIN and improve
the quality of life in patients after EVAR.
Table 4. Relationship between clinical outcomes and development of CIN and CV/eGFR1.62.
CIN (n=14) Non-CIN (n=189) Total (n=203) P-value
Hospital death, n (%) 2 (14.3) 1 (0.5) 3 (1.5) 0.013*
Renal replacement therapy, n (%) 1 (7.1) 0 (0) 1 (0.49) 0.335
ICU stay, days 4.073.26 2.442.62 2.731.69 0.029*
Hospital stay, days 17.211.0 10.97.5 11.47.9 0.004*
One-year mortality, n (%) 3 (21.4) 3 (1.6) 6 (3.0) 0.005*
CV/eGFR1.62 (n=72) CV/eGFR1.62 (n=131) Total (n=203) P-value
CIN, n (%) 11 (15) 3 (2.3) 14 (6.9) 0.001*
Hospital death, n (%) 3 (4.2) 0 (0) 3 (1.5) 0.043*
Renal replacement therapy, n (%) 1 (1.4) 0 (0) 1 (0.49) 0.335
ICU stay, days 2.944.43 2.330.63 2.731.69 0.127
Hospital stay, days 13.210.8 10.35.5 11.47.9 0.014*
One-year mortality, n (%) 5 (6.9) 1 (0.8) 6 (3.0) 0.022*
Values are presented as meanstandard deviation or n (%).
Abbreviations : ICU, intensive care unit ; CIN, contrast medium-induced nephropathy.
*Statistically significant.
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